|
|
||||||||
From the Freeman Hospital Stroke Service (Drs. Harbison and Ford) and Department of Diagnostic Imaging (Dr. ZammitMaempel), Freeman Hospital; and School of Clinical Medical Sciences (Dr. Gibson), University of Newcastle upon Tyne, and Department of Neuroradiology (Dr. Birchall), Newcastle General Hospital, Newcastle upon Tyne, UK.
Address correspondence and reprint requests to Dr. G.A. Ford, Wolfson Unit of Clinical Pharmacology, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK; e-mail: g.a.ford{at}ncl.ac.uk
Objective: To assess sleep-disordered breathing (SDB) in patients with acute stroke and its relationship to prestroke cerebrovascular disease, particularly leukoariosis.
Methods: The authors studied SDB and CT evidence of prestroke cerebrovascular disease, nonacute brain infarction, and white matter disease (WMD) in 78 previously independent patients with acute stroke. Subjects underwent respiratory sleep studies to determine the ApneaHypopnea Index (AHI) and Desaturation Index (DI) 7 to 14 days following stroke. CT scans were evaluated for severity of acute prestroke cerebrovascular disease and WMD severity.
Results: Prestroke cerebrovascular disease was present in 49 (63%) patients and was associated with worse SDB (mean AHI 35 vs 23, p < 0.01; mean DI 28 vs 18, p < 0.05), particularly in men (mean AHI 43 vs 27, p < 0.01). WMD severity correlated with AHI (r = 0.26, p < 0.05) and age (r = 0.56, p < 0.01). WMD severity in frontal and basal ganglia areas showed the strongest association. On multivariate analysis, WMD severity correlated independently with AHI (R2 = 0.07, p < 0.05).
Conclusions: The presence of prestroke cerebrovascular disease and severity of WMD are associated with worse SDB. These findings suggest that either white matter is particularly vulnerable to the hypoxia and blood pressure variability associated with SDB or that WMD is a major factor exacerbating SDB following stroke.
Received December 23, 2002. Accepted in final form June 26, 2003.
This article has been cited by other articles:
![]() |
W. T. McNicholas, M. R. Bonsignore, and the Management Committee of EU COST ACTION B26 Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities Eur. Respir. J., January 1, 2007; 29(1): 156 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Bassetti, M. Milanova, and M. Gugger Sleep-Disordered Breathing and Acute Ischemic Stroke: Diagnosis, Risk Factors, Treatment, Evolution, and Long-Term Clinical Outcome Stroke, April 1, 2006; 37(4): 967 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alchanatis, N. Deligiorgis, N. Zias, A. Amfilochiou, E. Gotsis, A. Karakatsani, and A. Papadimitriou Frontal brain lobe impairment in obstructive sleep apnoea: a proton MR spectroscopy study Eur. Respir. J., December 1, 2004; 24(6): 980 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
G J Gibson Sleep disordered breathing and the outcome of stroke Thorax, May 1, 2004; 59(5): 361 - 363. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |